| Completed | Impact of TURP on Quality of Life in Patients With Benign Prostatic Hyperplasia: A Retrospective Study NCT06995963 | Centre Hospitalier de Gonesse | — |
| Recruiting | EEAP Using Moses 2.0 Technology vs the Thulium Fiber Laser in Medium-Large Prostates NCT06565741 | Fundacio Puigvert | N/A |
| Not Yet Recruiting | EEP in Patients With Urodynamically Proven DU/DA NCT06452927 | EEPiDuDa Study Group | N/A |
| Recruiting | Clinical Application of the J-PET Scanner Prototype NCT06242119 | Jagiellonian University | — |
| Recruiting | Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer NCT06161506 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the Pro NCT06209307 | University of California, Irvine | N/A |
| Completed | The Effect of Using a Motivation Card on Pain and Number of Walking Steps After Prostate Surgery NCT06699563 | Trakya University | N/A |
| Unknown | To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Under NCT05851521 | Lyx Institute | N/A |
| Completed | Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prost NCT06568718 | NPO Petrovax | N/A |
| Completed | The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention NCT06319469 | Beni-Suef University | Phase 2 |
| Recruiting | Prostate Medication, Metabolism and Gut Microbiota NCT06001619 | Turku University Hospital | Phase 4 |
| Recruiting | Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men with BPH NCT05686525 | Rigshospitalet, Denmark | N/A |
| Unknown | Laser Vaporization of the Prostate: Comparing Between Ejaculatory Preserving and Non-ejaculatory Preserving Te NCT06091618 | Ain Shams University | N/A |
| Completed | Bipolar Transurethral Enucleation Versus Resection in the Treatment of Benign Prostatic Hyperplasia: a Compara NCT06294366 | Menoufia University | N/A |
| Completed | The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family Histo NCT05506735 | University of Baghdad | — |
| Unknown | Prostatic Hyperplasia Treatment and Cancer Prevention NCT03064282 | Manchanda Medical Clinic | EARLY_Phase 1 |
| Completed | The Clinical Efficacy of Rezūm Therapy Versus Bipolar Trans-urethral Resection of the Prostate for Treatment B NCT06116370 | Ain Shams University | N/A |
| Completed | SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes NCT06148259 | Kasr El Aini Hospital | N/A |
| Unknown | Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic NCT04588857 | Rigshospitalet, Denmark | Phase 4 |
| Completed | One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia. NCT06257654 | Hisar Intercontinental Hospital | — |
| Unknown | Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men W NCT05023824 | Gangnam Severance Hospital | Phase 3 |
| Unknown | Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA NCT04760483 | Urological Research Network, LLC | Phase 1 |
| Terminated | Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia NCT04398966 | University of North Carolina, Chapel Hill | N/A |
| Unknown | Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LU NCT04590534 | Benha University | Phase 2 |
| Completed | Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study NCT03228485 | Société Internationale d'Urologie | — |
| Unknown | Benign Prostatic Hyperplasia and Glycosaminoglycan NCT03955484 | Marmara University | — |
| Unknown | Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-infer NCT04108871 | The University of Hong Kong | N/A |
| Unknown | Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Res NCT03589196 | Mansoura University | N/A |
| Unknown | Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety NCT03554070 | I.M. Sechenov First Moscow State Medical University | N/A |
| Recruiting | Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer NCT03354416 | National Cancer Institute (NCI) | — |
| Completed | HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia NCT04561505 | Ain Shams University | N/A |
| Withdrawn | Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Amb NCT03474419 | Fondation Hôpital Saint-Joseph | — |
| Withdrawn | Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia NCT03179228 | John D Louie | N/A |
| Unknown | The Influence of Benign Prostatic Hyperplasia on Bladder Function NCT03098147 | Xiangfu Zhou | — |
| Completed | Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH NCT04331301 | Benha University | N/A |
| Completed | Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years NCT02757963 | GlaxoSmithKline | Phase 4 |
| Unknown | Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate NCT02749604 | Mansoura University | Phase 4 |
| Completed | Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms NCT02252367 | University of Florence | Phase 4 |
| Unknown | Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia NCT02592473 | University of Virginia | N/A |
| Completed | PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunte NCT02715401 | Hanmi Pharmaceutical Company Limited | Phase 1 |
| Terminated | Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than NCT02396420 | South Florida Medical Imaging, PA | Phase 2 |
| Completed | Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects NCT02578953 | GlaxoSmithKline | Phase 1 |
| Completed | Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative NCT02509104 | GlaxoSmithKline | Phase 1 |
| Unknown | Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan NCT02496442 | Flowmed | N/A |
| Completed | Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers NCT02712411 | Hanmi Pharmaceutical Company Limited | Phase 1 |
| Completed | HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH NCT02737241 | Mansoura University | N/A |
| Completed | Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. NCT02417831 | Boehringer Ingelheim | Phase 1 |
| Completed | Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. NCT02417844 | Boehringer Ingelheim | Phase 1 |
| Completed | Does Benign Prostatic Obstruction Cause Hypertension? NCT02347436 | St. Olavs Hospital | — |
| Completed | Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms NCT03936244 | Hospital Universitario de Fuenlabrada | N/A |
| Unknown | Digital Rectal Exam Proficiency Tool NCT02278679 | University of Virginia | — |
| Completed | Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyp NCT02947958 | Hospital de Clinicas de Porto Alegre | N/A |
| Unknown | Impact of Postoperative Pyuria on Treatment Outcomes After PVP NCT02241902 | DongGuk University | — |
| Unknown | Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the Prostate NCT02243085 | DongGuk University | — |
| Completed | Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hyd NCT02184585 | GlaxoSmithKline | Phase 1 |
| Unknown | Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy NCT02243540 | Seoul National University Hospital | — |
| Completed | Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulo NCT02058368 | GlaxoSmithKline | Phase 3 |
| Unknown | The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperp NCT02033798 | The Catholic University of Korea | N/A |
| Unknown | Storage Symptom After Laser Prostatectomy NCT02073799 | Seoul National University Hospital | — |
| Unknown | Functional Changes of Urogenital System After Holmium Laser Prostatectomy NCT02033785 | The Catholic University of Korea | — |
| Completed | Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic H NCT03385161 | Cairo University | N/A |
| Completed | Information Improvement for Surgical Patients Through Portable Video Media NCT02846467 | Hospital Universitario Puerto Real | N/A |
| Completed | This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmaco NCT01957189 | GlaxoSmithKline | Phase 1 |
| Completed | Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patien NCT02248467 | University of Florence | — |
| Completed | Prospective Sexual Function Study for BPH Subjects NCT01777269 | GlaxoSmithKline | Phase 4 |
| Completed | WEUSKOP5723: Prostate Cancer Study NCT01767363 | GlaxoSmithKline | — |
| Completed | TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST NCT02366975 | University of Florence | Phase 4 |
| Completed | Bioequivalence - Duodart Against Avodart & Omnic NCT01657851 | GlaxoSmithKline | Phase 1 |
| Terminated | Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign NCT01673490 | GlaxoSmithKline | Phase 4 |
| Completed | Rezum I Pilot Study for Benign Prostatic Hyperplasia NCT02943070 | Boston Scientific Corporation | N/A |
| Completed | A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) NCT01495026 | GlaxoSmithKline | Phase 1 |
| Completed | Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asi NCT01471678 | GlaxoSmithKline | Phase 1 |
| Completed | Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Hea NCT01577693 | GlaxoSmithKline | Phase 1 |
| Completed | A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy NCT01275521 | University Hospital, Bordeaux | Phase 3 |
| Completed | Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyl NCT01294592 | GlaxoSmithKline | Phase 4 |
| Completed | Drug Use Investigation for AVOLVE(BPH) NCT01376284 | GlaxoSmithKline | — |
| Completed | The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction NCT01482676 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of NCT01376258 | GlaxoSmithKline | — |
| Completed | A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsul NCT01254071 | GlaxoSmithKline | Phase 1 |
| Completed | Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Su NCT01332487 | GlaxoSmithKline | — |
| Completed | Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to NCT01381510 | GlaxoSmithKline | — |
| Completed | Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan NCT01323998 | GlaxoSmithKline | — |
| Completed | Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic H NCT01334723 | GlaxoSmithKline | — |
| Completed | SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin NCT01262989 | GlaxoSmithKline | Phase 1 |
| Completed | SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin NCT01330303 | GlaxoSmithKline | Phase 1 |
| Completed | Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) NCT01108367 | Seoul National University Hospital | — |
| Completed | Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alph NCT01332435 | GlaxoSmithKline | — |
| Completed | Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence NCT01390870 | GlaxoSmithKline | — |
| Completed | A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic H NCT01003886 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Completed | MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use NCT01050465 | University of Missouri-Columbia | N/A |
| Completed | MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Tr NCT00885027 | Boehringer Ingelheim | — |
| Completed | Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford NCT01386983 | GlaxoSmithKline | — |
| Completed | A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia NCT00793819 | Watson Pharmaceuticals | Phase 2 |
| Completed | Prostate Mechanical Imager (PMI) Clinical Bridging Study NCT00822952 | Artann Laboratories | — |
| Completed | A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Tolera NCT00814736 | Pfizer | Phase 1 |
| Completed | A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. NCT00609596 | GlaxoSmithKline | Phase 1 |
| Completed | Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia NCT00596011 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State NCT00537654 | GlaxoSmithKline | Phase 1 |
| Completed | Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) NCT00527605 | GlaxoSmithKline | Phase 3 |
| Completed | Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. NCT00457457 | Pfizer | Phase 2 |
| Completed | Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms NCT00408954 | Pfizer | Phase 2 |
| Completed | A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With NCT00510406 | Astellas Pharma Inc | Phase 2 |
| Completed | Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign NCT00399464 | Sanofi | Phase 3 |
| Completed | Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study NCT00427882 | Handok Inc. | Phase 4 |
| Terminated | ALF-STONE: Alfuzosin in Uretheric Stones NCT00454402 | Sanofi | Phase 3 |
| Completed | Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin NCT00401661 | Sanofi | Phase 4 |
| Completed | SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin NCT00486785 | Sanofi | Phase 4 |
| Completed | Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosi NCT00517179 | Hospital Authority, Hong Kong | N/A |
| Completed | Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia NCT02245555 | Boehringer Ingelheim | — |
| Completed | Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects NCT00368979 | GlaxoSmithKline | Phase 3 |
| Unknown | The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients NCT00497939 | Hospital Authority, Hong Kong | N/A |
| Terminated | Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Ac NCT00563485 | Hospital Authority, Hong Kong | N/A |
| Terminated | Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary NCT00563654 | Hospital Authority, Hong Kong | N/A |
| Completed | ALF-ONE : ALFuzosin ONcE Daily NCT00280605 | Sanofi | Phase 4 |
| Terminated | Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) NCT00116571 | QLT Inc. | Phase 2 |
| Completed | The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prost NCT02245542 | Boehringer Ingelheim | — |
| Completed | Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) NCT00169585 | GlaxoSmithKline | Phase 3 |
| Completed | Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia NCT02245529 | Boehringer Ingelheim | — |
| Completed | AVODART(Dutasteride) Post-marketing Surveillance(PMS) NCT01299571 | GlaxoSmithKline | — |
| Completed | Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS NCT00316732 | GlaxoSmithKline | — |
| Completed | Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems NCT00547625 | Eli Lilly and Company | Phase 2 |
| Completed | Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) NCT02244346 | Boehringer Ingelheim | — |
| Completed | Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) NCT02244333 | Boehringer Ingelheim | — |
| Completed | Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment NCT00090103 | GlaxoSmithKline | Phase 3 |
| Completed | Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels NCT00062790 | GlaxoSmithKline | Phase 4 |
| Completed | Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia NCT00969072 | GlaxoSmithKline | Phase 2 |
| Completed | Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) NCT02245503 | Boehringer Ingelheim | — |
| Completed | Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activ NCT02245490 | Boehringer Ingelheim | Phase 4 |
| Completed | Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytot NCT02244320 | Boehringer Ingelheim | — |
| Unknown | A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). NCT00044226 | Milkhaus Laboratory | Phase 2 |
| Completed | ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Pa NCT00290030 | Sanofi | Phase 3 |
| Completed | Clinical Trial in Males With BPH (Enlarged Prostate) NCT00029822 | Sanofi | Phase 3 |
| Completed | Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia NCT02244268 | Boehringer Ingelheim | — |
| Completed | Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Bloc NCT02244307 | Boehringer Ingelheim | — |
| Completed | FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia NCT02244255 | Boehringer Ingelheim | Phase 4 |
| Completed | Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Pros NCT02244242 | Boehringer Ingelheim | Phase 4 |
| Completed | Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperpl NCT02244229 | Boehringer Ingelheim | Phase 4 |
| Completed | Medical Therapy of Prostatic Symptoms NCT00021814 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |